
A study published in Advanced Science used three AI models to screen thousands of approved drugs, identifying nine that inhibit Streptococcus pneumoniae, a bacterium increasingly resistant to antibiotics.
Imagine being able to create a personalized care plan for a patient using their individual genetic profile to target the best therapies. It may sound like science fiction, but it’s very real.
But what exactly is it? What are the benefits and challenges that physicians need to know about?
Silas Inman sat down with Joel Diamond, MD, FAAFP, co-founder and chief medical officer of





